AVITA Medical (RCEL) EBIAT (2018 - 2025)
AVITA Medical's EBIAT history spans 8 years, with the latest figure at -$11.6 million for Q4 2025.
- For Q4 2025, EBIAT changed 0.28% year-over-year to -$11.6 million; the TTM value through Dec 2025 reached -$48.6 million, up 21.44%, while the annual FY2025 figure was -$48.6 million, 21.44% up from the prior year.
- EBIAT reached -$11.6 million in Q4 2025 per RCEL's latest filing, up from -$13.2 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of -$4.7 million in Q2 2021 to a low of -$18.7 million in Q1 2024.
- Average EBIAT over 5 years is -$10.0 million, with a median of -$9.5 million recorded in 2022.
- Peak YoY movement for EBIAT: soared 63.47% in 2021, then tumbled 102.36% in 2024.
- A 5-year view of EBIAT shows it stood at -$5.9 million in 2021, then increased by 10.0% to -$5.4 million in 2022, then crashed by 31.98% to -$7.1 million in 2023, then crashed by 64.03% to -$11.6 million in 2024, then decreased by 0.28% to -$11.6 million in 2025.
- Per Business Quant, the three most recent readings for RCEL's EBIAT are -$11.6 million (Q4 2025), -$13.2 million (Q3 2025), and -$9.9 million (Q2 2025).